AbbVie Puts Final Nail In Rova-T's Coffin After Another Trial Failure

 
• By Mandy Jackson
  
Rusty-nail
Rova-T was all but dead until the ADC's latest failure in SCLC. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D